https://pbs.twimg.com/media/F8vzH54XMAANsVf.jpg
Bimekizumab (Bimelex), a dual IL-17A/F inhibitor, is FDA approved for u Treatment of Adults with Moderate to Severe Plaque Psoriasis https://t.co/IeobNWcM94 https://t.co/OMbhVwFCCt

Links:

BIMZELX[®] Approved by the U.S. FDA for the Treatment of Adults with Moderate t… https://bit.ly/46WX4Kk
Dr. John Cush
RheumNow
18-10-2023
×